Mass spectrometric studies of the formation and reactivity of trans-[PtCl2(Am)(piperidinopiperidine)]·HCl complexes with ubiquitin

Rapid Communications in Mass Spectrometry

Volumn 19, Issue 24, 2005, Pages 3666-3672

  Balter, Liliana ^a   Gibson, Dan ^a,b  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

MASS SPECTROMETRY;

DIMETHYLAMINES; GLUTHATHIONE; PLATINUM COMPLEXES; TERNARY COMPLEX; UBIQUITIN;

PLATINUM COMPOUNDS;

EID: 29144445367     PISSN: 09514198     EISSN: None     Source Type: Journal    
DOI: 10.1002/rcm.2244     Document Type: Article

References (29)

1. Boulikas T, Vougiouka M. Oncol. Rep. 2004; 11: 559.
2. Zwelling LA. Cancer Chemother. Biol. Response Modif. 1988; 10: 64.
3. Wong E, Giandomenico CM. Chem. Rev. 1999; 99: 2451.
4. Farrell N, Ha TTB, Souchard JP, Wimmer FL, Cros S, Johnson NP. J. Med. Chem. 1989; 32: 2240.
5. Natile G, Coluccia M. Coord. Chem. Rev. 2001; 216: 383.
6. Perez JM, Fuertes MA, Alonso C, Navarro-Ranninger C. Crit. Rev. Oncol. Hematol. 2000; 35: 109.
7. Perez JM, Montero EI, Gonzalez AM, Solans X, Font-Bardia M, Fuertes MA, Alonso C, Navarro-Ranninger C. J. Med. Chem. 2000; 43: 2411.
8. Coluccia M, Nassi A, Boccarelli A, Giordano D, Cardellicchio N, Intini FP, Natile G, Barletta A, Paradiso A. Inter. J. Oncol. 1999; 15: 1039.
9. Vanbeusichem M, Farrell N. Inorg. Chem. 1992; 31: 634.
10. Najajreh Y, Perez JM, Navarro-Ranninger C, Gibson D. J. Med. Chem. 2002; 45: 5189.
11. Khazanov E, Barenholz Y, Gibson D, Najajreh Y. J. Med. Chem. 2002; 45: 5196.
12. Gomez-Quiroga A, Navarro-Ranninger C, Perez JM, Farrell N. J. Inorg. Biochem. 2001; 86: 237.
13. Siddik ZH. Oncogene 2003; 22: 7265.
14. Wang D, Lippard SJ. Nat. Rev. Drug Discov. 2005; 4: 307.
15. Cohen SM, Lippard SJ. Prog. Nucleic Acid Res. Mol. Biol. 2001; 67: 93.
16. Boulikas T, Vougiouka M. Oncol. Rep. 2003; 10: 1663.
17. Reedijk J. Chem. Rev. 1999; 99: 2499.
18. Brabec V, Kasparkova J. Drug Resistance Updates 2002; 5: 147.
19. Kartalou M, Essigmann JM. Mutat. Res. 2001; 478: 23.
20. van Boom S, Chen BW, Teuben JM, Reedijk J. Inorg. Chem. 1999; 38: 1450.
21. Marchan V, Pedroso E, Grandas A. Chem. Eur. J. 2004; 10: 5369.
22. Barnham KJ, Djuran MI, Murdoch PD, Sadler PJ. J. Chem. Soc. Chem. Commun. 1994; 721.
23. Najajreh Y, Prilutski D, Ardeli-Tzaraf Y, Perez JM, Khazanov E, Barenholz Y, Kasparkova J, Brabec V, Gibson D. Angew. Chem. Int. Edn. 2005; 44: 2885.
24. Gibson D, Costello C. Eur. Mass Spectrom. 1999; 5: 501.
25. Najajreh Y, Shulman TP, Moshel O, Farrell N, Gibson D. J. Biol. Inorg. Chem. 2003; 8: 167.
26. Peleg-Shulman T, Gibson D. J. Am. Chem. Soc. 2001; 123: 3171.
27. Bamezai S, Banez MA, Breslow E. Biochemistry 1990; 29: 5389.
28. Langford CH, Gray HB. Ligand Substitution Process. Benjamin: New York, 1965.
29. Appleton TG. Coord. Chem. Rev. 1997; 166: 313.